HomeCompareMMKT vs JNJ

MMKT vs JNJ: Dividend Comparison 2026

MMKT yields 3.85% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $4.6K in total portfolio value· pulled ahead in Year 9
10 years
MMKT
MMKT
● Live price
3.85%
Share price
$100.22
Annual div
$3.86
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.7K
Annual income
$492.96
Full MMKT calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — MMKT vs JNJ

📍 JNJ pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMMKTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MMKT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MMKT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MMKT
Annual income on $10K today (after 15% tax)
$327.22/yr
After 10yr DRIP, annual income (after tax)
$419.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,566.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MMKT + JNJ for your $10,000?

MMKT: 50%JNJ: 50%
100% JNJ50/50100% MMKT
Portfolio after 10yr
$28.0K
Annual income
$2,591.18/yr
Blended yield
9.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MMKT
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MMKT buys
0
JNJ buys
0
No recent congressional trades found for MMKT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMMKTJNJ
Forward yield3.85%2.13%
Annual dividend / share$3.86$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$25.7K$30.3K
Annual income after 10y$492.96$4,689.40
Total dividends collected$4.4K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MMKT vs JNJ ($10,000, DRIP)

YearMMKT PortfolioMMKT Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,085$384.96$10,592$272.30+$493.00MMKT
2$12,260$398.81$11,289$357.73+$971.00MMKT
3$13,530$412.22$12,123$472.89+$1.4KMMKT
4$14,902$425.18$13,141$629.86+$1.8KMMKT
5$16,383$437.66$14,408$846.81+$2.0KMMKT
6$17,980$449.67$16,021$1,151.60+$2.0KMMKT
7$19,700$461.21$18,122$1,588.22+$1.6KMMKT
8$21,551$472.27$20,930$2,228.20+$621.00MMKT
9← crossover$23,542$482.85$24,792$3,191.91$1.3KJNJ
10$25,683$492.96$30,274$4,689.40$4.6KJNJ

MMKT vs JNJ: Complete Analysis 2026

MMKTStock

MMKT is the first ETF to comply with Rule 2a-7 of the 1940 Act, technically qualifying as a government money market fund. The rule is designed to preserve stability and liquidity, ensuring that redemption requests can be fulfilled. However, MMKT will not maintain a stable net asset value (NAV) of $1. The fund will allocate at least 99.5% of its assets to cash, US government securities, or fully collateralized repurchase agreements. The objective is to generate competitive yields while preserving capital. Note that a significant portion of the funds assets are overnight repurchase agreements, and income from these may not be exempt from state and local taxes, which could affect the after-tax yield compared to traditional government securities.

Full MMKT Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this MMKT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MMKT vs SCHDMMKT vs JEPIMMKT vs OMMKT vs KOMMKT vs MAINMMKT vs ABBVMMKT vs MRKMMKT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.